S 1614

  • New Jersey Senate Bill
  • 2022-2023 Regular Session
  • Introduced in Senate Feb 14, 2022
  • Passed Senate Jun 29, 2022
  • Passed Assembly Jun 30, 2023
  • Signed by Governor Jul 10, 2023

Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.

Bill Subjects

Health Insur Pharmaceutic

Abstract

Bill Sponsors (30)

Park, Ellen J.

     
Cosponsor

Votes


Actions


Jul 10, 2023

Governor of New Jersey

Approved P.L.2023, c.105.

Jun 30, 2023

Assembly

Substituted for A2839 (2R)

Senate

Passed Senate (Passed Both Houses) (35-0)

Senate

Received in the Senate, 2nd Reading on Concurrence

Assembly

Passed Assembly (77-1-0)

Jun 27, 2023

Assembly

Recommitted to Assembly Budget Committee

Assembly

Reported out of Assembly Committee with Amendments, 2nd Reading

Jun 22, 2023

Assembly

Reported out of Assembly Committee, 2nd Reading

Jun 29, 2022

Assembly

Received in the Assembly, Referred to Assembly Appropriations Committee

Senate

Passed Senate (40-0)

Jun 27, 2022

Senate

Reported out of Senate Committee with Amendments, 2nd Reading

Mar 14, 2022

Senate

Referred to Senate Budget and Appropriations Committee

Senate

Reported out of Senate Committee, 2nd Reading

Feb 14, 2022

Senate

Introduced in the Senate, Referred to Senate Commerce Committee

Bill Text

Bill Text Versions Format
Introduced Version PDF HTML
Reprint SBA 6/27/22 1R PDF HTML
Reprint ABU 6/27/23 2R PDF HTML

Related Documents

Document Format
Statement ABU 6/27/23 1R
Statement AAP 6/22/2023
Statement SBA 6/27/22
Statement SCM 3/14/22
Legislative Fiscal Estimate 7/3/23; 2R
Legislative Fiscal Estimate 7/5/22; 1R
Legislative Fiscal Estimate 6/29/22; as introduced
Pamphlet Law
Advance Law

Sources

Data on Open States is updated periodically throughout the day from the official website of the New Jersey Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.